Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Icon plc Stock

Price
Target price
€280.00

€280.00

0.040%
0.1
0.040%
€318.99
 
11:58 / Tradegate WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Icon plc in the next few years
Wizard

Financial data and news for ICON

sharewise wants to provide you with the best news and tools for ICON, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

ICON Reports First Quarter 2024 Results: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Reports First Quarter 2024 Results


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the first quarter ended March 31, 2024.



CEO, Dr

BusinessWire_EN 
0 24.04.24
ICON Announces CFO Transition: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Announces CFO Transition


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in

BusinessWire_EN 
0 03.04.24
ICON plc Schedules First Quarter 2024 Earnings Conference Call: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc Schedules First Quarter 2024 Earnings Conference Call


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the

BusinessWire_EN 
0 25.03.24
ICON plc to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to Present at Upcoming Investor Conferences


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen

BusinessWire_EN 
0 26.02.24
ICON Reports Fourth Quarter and Full Year 2023 Results: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Reports Fourth Quarter and Full Year 2023 Results


ICON plc (NASDAQ:ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the fourth quarter and year ended December 31, 2023.

BusinessWire_EN 
0 21.02.24
 ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
 ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the fourth quarter and full year

BusinessWire_EN 
0 30.01.24
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent industry survey of over 100 professionals engaged

BusinessWire_EN 
0 24.01.24
ICON Issues Financial Guidance for Full Year 2024: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Issues Financial Guidance for Full Year 2024


ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2024. For the

BusinessWire_EN 
0 09.01.24
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today launched its “Optimising biotech funding” whitepaper. This provides an overview of the

BusinessWire_EN 
0 08.01.24
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P

BusinessWire_EN 
0 04.01.24
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positive recognition as a top-rated employer and

BusinessWire_EN 
0 18.12.23
ICON Secures Upgraded Credit Rating from Moody’s Investors Service: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Secures Upgraded Credit Rating from Moody’s Investors Service


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Moody's Investors Service ("Moody's") upgraded all of ICON plc’s instrument

BusinessWire_EN 
0 07.12.23
ICON plc to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to Present at Upcoming Investor Conferences


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the Jefferies

BusinessWire_EN 
0 08.11.23